Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation Plans and Awards (Tables)

v3.8.0.1
Stock-based Compensation Plans and Awards (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of shares available for grant and activity Shares available for grant as of December 31, 2017 and the activity during the year ended December 31, 2017 are as follows:
 
Shares Available for Grant
 
Equity Awards
 
ESPP
 
Total
Balance as of December 31, 2016
8,344,668

 
2,064,427

 
10,409,095

Additional shares authorized
9,406,510

 
6,000,000

 
15,406,510

Restricted stock units granted
(13,627,053
)
 

 
(13,627,053
)
Options granted
(2,226,443
)
 

 
(2,226,443
)
ESPP shares issued

 
(1,287,687
)
 
(1,287,687
)
Options forfeited
382,769

 

 
382,769

Options expired
1,469,714

 

 
1,469,714

Restricted stock units forfeited
7,089,976

 

 
7,089,976

Performance units forfeited*
883,169

 

 
883,169

Balance as of December 31, 2017
11,723,310

 
6,776,740

 
18,500,050

*Includes shares forfeited for MSUs and PSUs
Schedule of assumptions used for determining the per-share fair value of shares granted under the ESPP     
 
Year Ended December 31,
 
2015
 
2016
 
2017
Expected term (in years)
0.5

 
0.5

 
0.5

Risk-free interest rate
0.12
%
 
0.36
%
 
0.78
%
Expected volatility
52
%
 
44
%
 
45
%
Expected dividend yield
0
%
 
0
%
 
0
%
Schedule of stock option activity Stock option activity during the year ended December 31, 2017 was as follows:
 
Options Outstanding
 
Outstanding
Stock Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term (in years)
 
Aggregate Intrinsic Value (1)
 
(in thousands, except share and per share data)
Balance as of December 31, 2016
9,436,380

 
$
5.74

 
0.47
 
$
77,752

Granted
2,226,938

 
9.80

 
 
 
 
Exercised
(4,968,577
)
 
1.97

 
 
 
 
Forfeited
(903,112
)
 
7.69

 
 
 
 
Expired
(1,469,714
)
 
16.15

 
 
 
 
Balance as of December 31, 2017
4,321,915

 
8.90

 
5.84
 
2,922

Vested and exercisable as of December 31, 2017
2,616,163

 
8.55

 
3.43
 
2,918

Expected to vest as of December 31, 2017
1,705,752

 
$
9.45

 
9.53
 
$
4

 
 
 
 
 
 
 
 
(1)Amounts represent the difference between the exercise price and the fair value of common stock at each period end for all in the money options outstanding based on the fair value per share of common stock of $13.04 and $4.82 as of December 31, 2016 and 2017.
 
 

Schedule of assumptions used for estimating the per-share fair value of stock options
 
Year Ended December 31,
 
2015
 
2016
 
2017
Expected term (in years)
6.08

 
N/A
 
5.93 - 6.25

Risk-free interest rate
1.75% - 1.92%

 
N/A
 
1.92% - 2.18%

Expected volatility
49% - 50%

 
N/A
 
61
%
Expected dividend yield
0
%
 
N/A
 
0
%
Schedule of activities for RSUs and MSUs The following table summarizes the activities for our MSUs for the year ended December 31, 2017:

 
Number of MSUs
 
Weighted-Average Grant Date Fair Value
Unvested as of December 31, 2016
533,383

 
$
5.49

Forfeited
(217,387
)
 
5.64

Unvested as of December 31, 2017
315,996

 
5.38

Expected to vest as of December 31, 2017
113,672

 
$
5.38

The following table summarizes the activities for our PSUs for the year ended December 31, 2017:

 
Number of PSUs
 
Weighted-Average Grant Date Fair Value
Unvested as of December 31, 2016
1,835,250

 
$
5.33

Forfeited
(665,782
)
 
5.55

Unvested as of December 31, 2017
1,169,468

 
5.21

Expected to vest as of December 31, 2017
544,392

 
$
5.09

The following table summarizes the activities for our RSUs for the year ended December 31, 2017:

 
Number of RSUs
 
Weighted-Average Grant Date Fair Value
Unvested as of December 31, 2016
22,404,417

 
$
13.26

Granted
13,627,053

 
10.13

Vested
(9,478,804
)
 
13.80

Forfeited
(7,277,071
)
 
12.16

Unvested as of December 31, 2017
19,275,595

 
11.19

Expected to vest as of December 31, 2017
19,275,595

 
$
11.19

Schedule of stock-based compensation expenses related to all employee and non-employee stock-based awards Stock-based compensation expense related to all employee and non-employee stock-based awards was as follows:
 
 
Year ended December 31,
 
2015
 
2016
 
2017
 
(in thousands)
Stock-based compensation expense
 

 
 

 
 

Cost of revenue—Other
$
5,531

 
$
6,108

 
$
3,249

Cost of revenue—Ticketing service
40

 
188

 
69

Product development
23,671

 
30,975

 
33,243

Sales and marketing
52,747

 
58,118

 
56,116

General and administrative
29,656

 
43,069

 
35,754

Total stock-based compensation expense
$
111,645

 
$
138,458

 
$
128,431